Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
NCT06821087
·
clinicaltrials.gov ↗
PHASE2
Phase
ENROLLING_BY_INVITATION
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Long COVID
Interventions
DRUG:
Ketamine only
Sponsor
University of Texas at Austin
Collaborators
[object Object]